nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—Spironolactone—dilated cardiomyopathy	0.407	1	CrCtD
Hydrocortisone—CYP11B2—Spironolactone—dilated cardiomyopathy	0.106	0.37	CbGbCtD
Hydrocortisone—CYP11B1—Spironolactone—dilated cardiomyopathy	0.069	0.24	CbGbCtD
Hydrocortisone—SHBG—Spironolactone—dilated cardiomyopathy	0.0458	0.16	CbGbCtD
Hydrocortisone—Eplerenone—Spironolactone—dilated cardiomyopathy	0.0315	0.118	CrCrCtD
Hydrocortisone—Drospirenone—Spironolactone—dilated cardiomyopathy	0.0251	0.0935	CrCrCtD
Hydrocortisone—Dydrogesterone—Spironolactone—dilated cardiomyopathy	0.0251	0.0935	CrCrCtD
Hydrocortisone—NR3C1—Spironolactone—dilated cardiomyopathy	0.0244	0.085	CbGbCtD
Hydrocortisone—Potassium Canrenoate—Spironolactone—dilated cardiomyopathy	0.0239	0.0891	CrCrCtD
Hydrocortisone—Megestrol acetate—Spironolactone—dilated cardiomyopathy	0.0218	0.0815	CrCrCtD
Hydrocortisone—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.021	0.0733	CbGbCtD
Hydrocortisone—Medroxyprogesterone Acetate—Spironolactone—dilated cardiomyopathy	0.0194	0.0725	CrCrCtD
Hydrocortisone—Hydrocortamate—Spironolactone—dilated cardiomyopathy	0.0175	0.0654	CrCrCtD
Hydrocortisone—Cortisone acetate—Spironolactone—dilated cardiomyopathy	0.017	0.0634	CrCrCtD
Hydrocortisone—Fluoxymesterone—Spironolactone—dilated cardiomyopathy	0.0152	0.0566	CrCrCtD
Hydrocortisone—Progesterone—Spironolactone—dilated cardiomyopathy	0.0148	0.0551	CrCrCtD
Hydrocortisone—Testosterone Propionate—Spironolactone—dilated cardiomyopathy	0.0148	0.0551	CrCrCtD
Hydrocortisone—Fludrocortisone—Spironolactone—dilated cardiomyopathy	0.0148	0.0551	CrCrCtD
Hydrocortisone—Methyltestosterone—Spironolactone—dilated cardiomyopathy	0.0144	0.0537	CrCrCtD
Hydrocortisone—Testosterone—Spironolactone—dilated cardiomyopathy	0.0128	0.0478	CrCrCtD
Hydrocortisone—CYP2C8—Spironolactone—dilated cardiomyopathy	0.00839	0.0293	CbGbCtD
Hydrocortisone—ABCB1—Lisinopril—dilated cardiomyopathy	0.00645	0.0225	CbGbCtD
Hydrocortisone—ABCB1—Spironolactone—dilated cardiomyopathy	0.00568	0.0198	CbGbCtD
Hydrocortisone—Hypertrichosis—Spironolactone—dilated cardiomyopathy	0.00147	0.0576	CcSEcCtD
Hydrocortisone—CYP11B2—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.00123	0.116	CbGpPWpGaD
Hydrocortisone—Glucose tolerance impaired—Furosemide—dilated cardiomyopathy	0.00113	0.0443	CcSEcCtD
Hydrocortisone—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.00101	0.0396	CcSEcCtD
Hydrocortisone—CYP11B2—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.000959	0.0905	CbGpPWpGaD
Hydrocortisone—Skin infection—Lisinopril—dilated cardiomyopathy	0.000758	0.0296	CcSEcCtD
Hydrocortisone—Application site pain—Furosemide—dilated cardiomyopathy	0.000693	0.0271	CcSEcCtD
Hydrocortisone—Diabetic—Lisinopril—dilated cardiomyopathy	0.000685	0.0268	CcSEcCtD
Hydrocortisone—Pancreatitis acute—Furosemide—dilated cardiomyopathy	0.00066	0.0258	CcSEcCtD
Hydrocortisone—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.000638	0.0249	CcSEcCtD
Hydrocortisone—Vasculitis—Spironolactone—dilated cardiomyopathy	0.000574	0.0224	CcSEcCtD
Hydrocortisone—CYP11B2—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.000518	0.0489	CbGpPWpGaD
Hydrocortisone—Eruption—Furosemide—dilated cardiomyopathy	0.000496	0.0194	CcSEcCtD
Hydrocortisone—CYP11B2—ACE Inhibitor Pathway—ACE—dilated cardiomyopathy	0.000442	0.0417	CbGpPWpGaD
Hydrocortisone—Lethargy—Spironolactone—dilated cardiomyopathy	0.000415	0.0162	CcSEcCtD
Hydrocortisone—Blindness—Lisinopril—dilated cardiomyopathy	0.000413	0.0162	CcSEcCtD
Hydrocortisone—CYP11B2—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.000398	0.0376	CbGpPWpGaD
Hydrocortisone—Glycosuria—Furosemide—dilated cardiomyopathy	0.000376	0.0147	CcSEcCtD
Hydrocortisone—SHBG—Nongenotropic Androgen signaling—RAC1—dilated cardiomyopathy	0.000332	0.0314	CbGpPWpGaD
Hydrocortisone—Eplerenone—NR3C2—dilated cardiomyopathy	0.000323	0.184	CrCbGaD
Hydrocortisone—Vasculitis—Furosemide—dilated cardiomyopathy	0.000312	0.0122	CcSEcCtD
Hydrocortisone—Drospirenone—NR3C2—dilated cardiomyopathy	0.000309	0.177	CrCbGaD
Hydrocortisone—Fludrocortisone—NR3C2—dilated cardiomyopathy	0.000291	0.166	CrCbGaD
Hydrocortisone—CYP11B2—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.00028	0.0265	CbGpPWpGaD
Hydrocortisone—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.000276	0.0108	CcSEcCtD
Hydrocortisone—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.000256	0.00999	CcSEcCtD
Hydrocortisone—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000254	0.00995	CcSEcCtD
Hydrocortisone—Viral infection—Lisinopril—dilated cardiomyopathy	0.000253	0.0099	CcSEcCtD
Hydrocortisone—Arthropathy—Lisinopril—dilated cardiomyopathy	0.000252	0.00983	CcSEcCtD
Hydrocortisone—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.000243	0.00952	CcSEcCtD
Hydrocortisone—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000234	0.00916	CcSEcCtD
Hydrocortisone—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000229	0.00894	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000227	0.00889	CcSEcCtD
Hydrocortisone—Lethargy—Furosemide—dilated cardiomyopathy	0.000226	0.00883	CcSEcCtD
Hydrocortisone—Malaise—Spironolactone—dilated cardiomyopathy	0.000221	0.00864	CcSEcCtD
Hydrocortisone—SHBG—Nongenotropic Androgen signaling—RAF1—dilated cardiomyopathy	0.00022	0.0208	CbGpPWpGaD
Hydrocortisone—Spironolactone—NR3C2—dilated cardiomyopathy	0.00022	0.126	CrCbGaD
Hydrocortisone—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000217	0.00849	CcSEcCtD
Hydrocortisone—Neuropathy—Lisinopril—dilated cardiomyopathy	0.000215	0.0084	CcSEcCtD
Hydrocortisone—Irritability—Furosemide—dilated cardiomyopathy	0.000211	0.00826	CcSEcCtD
Hydrocortisone—Discomfort—Spironolactone—dilated cardiomyopathy	0.000206	0.00806	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000204	0.00796	CcSEcCtD
Hydrocortisone—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000201	0.00787	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0002	0.00782	CcSEcCtD
Hydrocortisone—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000195	0.00763	CcSEcCtD
Hydrocortisone—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000193	0.00753	CcSEcCtD
Hydrocortisone—Prednisolone—NR3C2—dilated cardiomyopathy	0.000191	0.109	CrCbGaD
Hydrocortisone—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000191	0.00746	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000189	0.0178	CbGpPWpGaD
Hydrocortisone—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000188	0.00733	CcSEcCtD
Hydrocortisone—Betamethasone—NR3C2—dilated cardiomyopathy	0.000187	0.107	CrCbGaD
Hydrocortisone—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000187	0.00732	CcSEcCtD
Hydrocortisone—Eczema—Lisinopril—dilated cardiomyopathy	0.000185	0.00722	CcSEcCtD
Hydrocortisone—Injury—Lisinopril—dilated cardiomyopathy	0.000181	0.00706	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000173	0.00675	CcSEcCtD
Hydrocortisone—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000172	0.00671	CcSEcCtD
Hydrocortisone—NR3C1—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000171	0.0162	CbGpPWpGaD
Hydrocortisone—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000166	0.00649	CcSEcCtD
Hydrocortisone—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000165	0.00644	CcSEcCtD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000161	0.0152	CbGpPWpGaD
Hydrocortisone—Urticaria—Spironolactone—dilated cardiomyopathy	0.000159	0.00621	CcSEcCtD
Hydrocortisone—Irritability—Lisinopril—dilated cardiomyopathy	0.000158	0.0062	CcSEcCtD
Hydrocortisone—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000158	0.00618	CcSEcCtD
Hydrocortisone—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000158	0.00617	CcSEcCtD
Hydrocortisone—ANXA1—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.00015	0.0141	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000147	0.00576	CcSEcCtD
Hydrocortisone—Eye disorder—Furosemide—dilated cardiomyopathy	0.000143	0.00559	CcSEcCtD
Hydrocortisone—Pruritus—Spironolactone—dilated cardiomyopathy	0.000141	0.00553	CcSEcCtD
Hydrocortisone—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000141	0.0055	CcSEcCtD
Hydrocortisone—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00014	0.00547	CcSEcCtD
Hydrocortisone—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000138	0.00541	CcSEcCtD
Hydrocortisone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000137	0.00535	CcSEcCtD
Hydrocortisone—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000137	0.00535	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000133	0.00521	CcSEcCtD
Hydrocortisone—Malnutrition—Furosemide—dilated cardiomyopathy	0.000133	0.00521	CcSEcCtD
Hydrocortisone—Erythema—Furosemide—dilated cardiomyopathy	0.000133	0.00521	CcSEcCtD
Hydrocortisone—Dizziness—Spironolactone—dilated cardiomyopathy	0.000132	0.00517	CcSEcCtD
Hydrocortisone—Weight increased—Lisinopril—dilated cardiomyopathy	0.000131	0.00511	CcSEcCtD
Hydrocortisone—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00013	0.00508	CcSEcCtD
Hydrocortisone—Vomiting—Spironolactone—dilated cardiomyopathy	0.000127	0.00497	CcSEcCtD
Hydrocortisone—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000126	0.00493	CcSEcCtD
Hydrocortisone—Rash—Spironolactone—dilated cardiomyopathy	0.000126	0.00493	CcSEcCtD
Hydrocortisone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000126	0.00492	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000125	0.0049	CcSEcCtD
Hydrocortisone—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000125	0.0049	CcSEcCtD
Hydrocortisone—Headache—Spironolactone—dilated cardiomyopathy	0.000125	0.0049	CcSEcCtD
Hydrocortisone—Vertigo—Furosemide—dilated cardiomyopathy	0.00012	0.00468	CcSEcCtD
Hydrocortisone—Progesterone—NR3C2—dilated cardiomyopathy	0.000119	0.0681	CrCbGaD
Hydrocortisone—Nausea—Spironolactone—dilated cardiomyopathy	0.000119	0.00464	CcSEcCtD
Hydrocortisone—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000117	0.00457	CcSEcCtD
Hydrocortisone—Hallucination—Lisinopril—dilated cardiomyopathy	0.000114	0.00447	CcSEcCtD
Hydrocortisone—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000113	0.0107	CbGpPWpGaD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000113	0.00441	CcSEcCtD
Hydrocortisone—ANXA1—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.000111	0.0105	CbGpPWpGaD
Hydrocortisone—Dexamethasone—NR3C2—dilated cardiomyopathy	0.000109	0.0623	CrCbGaD
Hydrocortisone—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000109	0.00425	CcSEcCtD
Hydrocortisone—Shock—Furosemide—dilated cardiomyopathy	0.000107	0.00418	CcSEcCtD
Hydrocortisone—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000107	0.00417	CcSEcCtD
Hydrocortisone—Skin disorder—Furosemide—dilated cardiomyopathy	0.000106	0.00413	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000105	0.00411	CcSEcCtD
Hydrocortisone—Anorexia—Furosemide—dilated cardiomyopathy	0.000104	0.00405	CcSEcCtD
Hydrocortisone—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000103	0.00401	CcSEcCtD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000102	0.00966	CbGpPWpGaD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000102	0.00966	CbGpPWpGaD
Hydrocortisone—Hypotension—Furosemide—dilated cardiomyopathy	0.000102	0.00397	CcSEcCtD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000101	0.00955	CbGpPWpGaD
Hydrocortisone—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000101	0.00393	CcSEcCtD
Hydrocortisone—Erythema—Lisinopril—dilated cardiomyopathy	0.0001	0.00391	CcSEcCtD
Hydrocortisone—Malnutrition—Lisinopril—dilated cardiomyopathy	0.0001	0.00391	CcSEcCtD
Hydrocortisone—Paraesthesia—Furosemide—dilated cardiomyopathy	9.77e-05	0.00382	CcSEcCtD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	9.51e-05	0.00898	CbGpPWpGaD
Hydrocortisone—Decreased appetite—Furosemide—dilated cardiomyopathy	9.46e-05	0.0037	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	9.39e-05	0.00367	CcSEcCtD
Hydrocortisone—Fatigue—Furosemide—dilated cardiomyopathy	9.38e-05	0.00367	CcSEcCtD
Hydrocortisone—Pain—Furosemide—dilated cardiomyopathy	9.3e-05	0.00364	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	9.28e-05	0.00363	CcSEcCtD
Hydrocortisone—Angioedema—Lisinopril—dilated cardiomyopathy	9.14e-05	0.00357	CcSEcCtD
Hydrocortisone—Malaise—Lisinopril—dilated cardiomyopathy	9.02e-05	0.00353	CcSEcCtD
Hydrocortisone—Vertigo—Lisinopril—dilated cardiomyopathy	8.98e-05	0.00351	CcSEcCtD
Hydrocortisone—Syncope—Lisinopril—dilated cardiomyopathy	8.97e-05	0.00351	CcSEcCtD
Hydrocortisone—Feeling abnormal—Furosemide—dilated cardiomyopathy	8.96e-05	0.0035	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	8.9e-05	0.00348	CcSEcCtD
Hydrocortisone—Loss of consciousness—Lisinopril—dilated cardiomyopathy	8.79e-05	0.00344	CcSEcCtD
Hydrocortisone—Urticaria—Furosemide—dilated cardiomyopathy	8.64e-05	0.00338	CcSEcCtD
Hydrocortisone—ANXA1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	8.63e-05	0.00815	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	8.63e-05	0.00815	CbGpPWpGaD
Hydrocortisone—Abdominal pain—Furosemide—dilated cardiomyopathy	8.6e-05	0.00336	CcSEcCtD
Hydrocortisone—Body temperature increased—Furosemide—dilated cardiomyopathy	8.6e-05	0.00336	CcSEcCtD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—GJA1—dilated cardiomyopathy	8.59e-05	0.00811	CbGpPWpGaD
Hydrocortisone—Myalgia—Lisinopril—dilated cardiomyopathy	8.51e-05	0.00333	CcSEcCtD
Hydrocortisone—Anxiety—Lisinopril—dilated cardiomyopathy	8.48e-05	0.00332	CcSEcCtD
Hydrocortisone—ANXA1—Spinal Cord Injury—RAC1—dilated cardiomyopathy	8.48e-05	0.00801	CbGpPWpGaD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	8.46e-05	0.00331	CcSEcCtD
Hydrocortisone—Discomfort—Lisinopril—dilated cardiomyopathy	8.41e-05	0.00329	CcSEcCtD
Hydrocortisone—NR3C1—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	8.36e-05	0.00789	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.34e-05	0.00788	CbGpPWpGaD
Hydrocortisone—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	8.16e-05	0.00319	CcSEcCtD
Hydrocortisone—Oedema—Lisinopril—dilated cardiomyopathy	8.16e-05	0.00319	CcSEcCtD
Hydrocortisone—Infection—Lisinopril—dilated cardiomyopathy	8.11e-05	0.00317	CcSEcCtD
Hydrocortisone—Shock—Lisinopril—dilated cardiomyopathy	8.03e-05	0.00314	CcSEcCtD
Hydrocortisone—ANXA1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	8.02e-05	0.00757	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Furosemide—dilated cardiomyopathy	8.01e-05	0.00313	CcSEcCtD
Hydrocortisone—Tachycardia—Lisinopril—dilated cardiomyopathy	7.97e-05	0.00311	CcSEcCtD
Hydrocortisone—ANXA1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	7.97e-05	0.00752	CbGpPWpGaD
Hydrocortisone—Skin disorder—Lisinopril—dilated cardiomyopathy	7.93e-05	0.0031	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	7.89e-05	0.00308	CcSEcCtD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	7.86e-05	0.00743	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.84e-05	0.0074	CbGpPWpGaD
Hydrocortisone—Asthenia—Furosemide—dilated cardiomyopathy	7.8e-05	0.00305	CcSEcCtD
Hydrocortisone—Anorexia—Lisinopril—dilated cardiomyopathy	7.78e-05	0.00304	CcSEcCtD
Hydrocortisone—Pruritus—Furosemide—dilated cardiomyopathy	7.7e-05	0.00301	CcSEcCtD
Hydrocortisone—Hypotension—Lisinopril—dilated cardiomyopathy	7.63e-05	0.00298	CcSEcCtD
Hydrocortisone—Diarrhoea—Furosemide—dilated cardiomyopathy	7.44e-05	0.00291	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	7.44e-05	0.00291	CcSEcCtD
Hydrocortisone—Insomnia—Lisinopril—dilated cardiomyopathy	7.38e-05	0.00289	CcSEcCtD
Hydrocortisone—Paraesthesia—Lisinopril—dilated cardiomyopathy	7.33e-05	0.00286	CcSEcCtD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	7.2e-05	0.0068	CbGpPWpGaD
Hydrocortisone—Dizziness—Furosemide—dilated cardiomyopathy	7.19e-05	0.00281	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.19e-05	0.00679	CbGpPWpGaD
Hydrocortisone—Dyspepsia—Lisinopril—dilated cardiomyopathy	7.18e-05	0.00281	CcSEcCtD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	7.12e-05	0.00673	CbGpPWpGaD
Hydrocortisone—Decreased appetite—Lisinopril—dilated cardiomyopathy	7.1e-05	0.00277	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	7.05e-05	0.00275	CcSEcCtD
Hydrocortisone—Fatigue—Lisinopril—dilated cardiomyopathy	7.04e-05	0.00275	CcSEcCtD
Hydrocortisone—Pain—Lisinopril—dilated cardiomyopathy	6.98e-05	0.00273	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	6.96e-05	0.00657	CbGpPWpGaD
Hydrocortisone—Vomiting—Furosemide—dilated cardiomyopathy	6.92e-05	0.0027	CcSEcCtD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	6.86e-05	0.00648	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	6.86e-05	0.00648	CbGpPWpGaD
Hydrocortisone—Rash—Furosemide—dilated cardiomyopathy	6.86e-05	0.00268	CcSEcCtD
Hydrocortisone—Dermatitis—Furosemide—dilated cardiomyopathy	6.85e-05	0.00268	CcSEcCtD
Hydrocortisone—Headache—Furosemide—dilated cardiomyopathy	6.81e-05	0.00266	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.76e-05	0.00638	CbGpPWpGaD
Hydrocortisone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	6.73e-05	0.00263	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	6.67e-05	0.00261	CcSEcCtD
Hydrocortisone—Urticaria—Lisinopril—dilated cardiomyopathy	6.48e-05	0.00253	CcSEcCtD
Hydrocortisone—Nausea—Furosemide—dilated cardiomyopathy	6.46e-05	0.00253	CcSEcCtD
Hydrocortisone—Body temperature increased—Lisinopril—dilated cardiomyopathy	6.45e-05	0.00252	CcSEcCtD
Hydrocortisone—Abdominal pain—Lisinopril—dilated cardiomyopathy	6.45e-05	0.00252	CcSEcCtD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	6.38e-05	0.00602	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	6.18e-05	0.00583	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	6.1e-05	0.00576	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	6.01e-05	0.00235	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	5.88e-05	0.00556	CbGpPWpGaD
Hydrocortisone—Asthenia—Lisinopril—dilated cardiomyopathy	5.86e-05	0.00229	CcSEcCtD
Hydrocortisone—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	5.84e-05	0.00552	CbGpPWpGaD
Hydrocortisone—Pruritus—Lisinopril—dilated cardiomyopathy	5.77e-05	0.00226	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	5.77e-05	0.00545	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	5.61e-05	0.00529	CbGpPWpGaD
Hydrocortisone—Diarrhoea—Lisinopril—dilated cardiomyopathy	5.58e-05	0.00218	CcSEcCtD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	5.53e-05	0.00523	CbGpPWpGaD
Hydrocortisone—Dizziness—Lisinopril—dilated cardiomyopathy	5.4e-05	0.00211	CcSEcCtD
Hydrocortisone—NR3C1—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	5.34e-05	0.00504	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	5.28e-05	0.00498	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	5.22e-05	0.00493	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	5.22e-05	0.00493	CbGpPWpGaD
Hydrocortisone—Vomiting—Lisinopril—dilated cardiomyopathy	5.19e-05	0.00203	CcSEcCtD
Hydrocortisone—Rash—Lisinopril—dilated cardiomyopathy	5.15e-05	0.00201	CcSEcCtD
Hydrocortisone—Dermatitis—Lisinopril—dilated cardiomyopathy	5.14e-05	0.00201	CcSEcCtD
Hydrocortisone—Headache—Lisinopril—dilated cardiomyopathy	5.11e-05	0.002	CcSEcCtD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	5.01e-05	0.00473	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	5e-05	0.00473	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	4.86e-05	0.00459	CbGpPWpGaD
Hydrocortisone—Nausea—Lisinopril—dilated cardiomyopathy	4.85e-05	0.0019	CcSEcCtD
Hydrocortisone—ANXA1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	4.7e-05	0.00444	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	4.67e-05	0.00441	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IL10—dilated cardiomyopathy	4.63e-05	0.00437	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.51e-05	0.00426	CbGpPWpGaD
Hydrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—dilated cardiomyopathy	4.45e-05	0.0042	CbGpPWpGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	4.34e-05	0.0041	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—LMNA—dilated cardiomyopathy	4.33e-05	0.00409	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.24e-05	0.004	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	4.12e-05	0.00389	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.02e-05	0.00379	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—AGT—dilated cardiomyopathy	3.89e-05	0.00367	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—EGFR—dilated cardiomyopathy	3.86e-05	0.00364	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	3.82e-05	0.00361	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	3.81e-05	0.0036	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—ANKRD1—dilated cardiomyopathy	3.71e-05	0.00351	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	3.71e-05	0.00351	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—TNF—dilated cardiomyopathy	3.67e-05	0.00347	CbGpPWpGaD
Hydrocortisone—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	3.58e-05	0.00338	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—TAZ—dilated cardiomyopathy	3.49e-05	0.0033	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	3.48e-05	0.00329	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	3.2e-05	0.00302	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—ANKRD1—dilated cardiomyopathy	3.2e-05	0.00302	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	3.17e-05	0.00299	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—SDHA—dilated cardiomyopathy	3.16e-05	0.00298	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.05e-05	0.00288	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—TAZ—dilated cardiomyopathy	3.01e-05	0.00284	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.97e-05	0.0028	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.97e-05	0.0028	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	2.96e-05	0.0028	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	2.95e-05	0.00279	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	2.95e-05	0.00279	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—AGT—dilated cardiomyopathy	2.83e-05	0.00267	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	2.81e-05	0.00266	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.76e-05	0.00261	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.74e-05	0.00259	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—SDHA—dilated cardiomyopathy	2.72e-05	0.00257	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	2.69e-05	0.00254	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.68e-05	0.00253	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.68e-05	0.00253	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.66e-05	0.00251	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.62e-05	0.00248	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—FAS—dilated cardiomyopathy	2.53e-05	0.00239	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.5e-05	0.00236	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.49e-05	0.00235	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	2.44e-05	0.0023	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.42e-05	0.00228	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.41e-05	0.00228	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	2.39e-05	0.00225	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—AGT—dilated cardiomyopathy	2.37e-05	0.00224	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.35e-05	0.00222	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.35e-05	0.00222	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.27e-05	0.00214	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	2.26e-05	0.00213	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.21e-05	0.00209	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.19e-05	0.00206	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.15e-05	0.00203	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	2.1e-05	0.00198	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.08e-05	0.00197	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.06e-05	0.00195	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	2.02e-05	0.00191	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	2.01e-05	0.0019	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.96e-05	0.00185	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.93e-05	0.00182	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	1.89e-05	0.00178	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.88e-05	0.00177	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	1.86e-05	0.00176	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.78e-05	0.00168	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	1.71e-05	0.00161	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.69e-05	0.0016	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.67e-05	0.00158	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.66e-05	0.00157	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.62e-05	0.00153	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.6e-05	0.00151	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	1.59e-05	0.0015	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.58e-05	0.0015	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.58e-05	0.0015	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	1.58e-05	0.00149	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.52e-05	0.00143	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	1.49e-05	0.00141	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	1.48e-05	0.0014	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.47e-05	0.00139	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.46e-05	0.00137	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.45e-05	0.00137	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.43e-05	0.00135	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—NR3C2—dilated cardiomyopathy	1.43e-05	0.00135	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	1.35e-05	0.00128	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	1.34e-05	0.00126	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	1.31e-05	0.00123	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	1.27e-05	0.0012	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	1.27e-05	0.0012	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.22e-05	0.00115	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.18e-05	0.00112	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.16e-05	0.00109	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	1.14e-05	0.00108	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—TNF—dilated cardiomyopathy	1.07e-05	0.00101	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	1.07e-05	0.00101	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.04e-05	0.000983	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	1.04e-05	0.000978	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.01e-05	0.000957	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.01e-05	0.000951	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	9.99e-06	0.000943	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.93e-06	0.000937	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	9.86e-06	0.000931	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	9.79e-06	0.000925	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	9.68e-06	0.000914	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	9.28e-06	0.000876	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	9.27e-06	0.000876	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.13e-06	0.000862	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—RAC1—dilated cardiomyopathy	8.97e-06	0.000847	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—NPPA—dilated cardiomyopathy	8.95e-06	0.000845	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	8.59e-06	0.000812	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	8.59e-06	0.000811	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—GPX1—dilated cardiomyopathy	8.58e-06	0.00081	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—AGT—dilated cardiomyopathy	8.57e-06	0.000809	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	8.39e-06	0.000792	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—CD36—dilated cardiomyopathy	8.35e-06	0.000789	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	8.08e-06	0.000763	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—AGT—dilated cardiomyopathy	7.52e-06	0.00071	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—GPX1—dilated cardiomyopathy	7.39e-06	0.000698	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	7.31e-06	0.00069	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—CD36—dilated cardiomyopathy	7.2e-06	0.00068	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.9e-06	0.000652	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	6.49e-06	0.000613	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—AGT—dilated cardiomyopathy	6.48e-06	0.000612	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.02e-06	0.000569	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—RAF1—dilated cardiomyopathy	5.95e-06	0.000562	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	5.29e-06	0.0005	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.11e-06	0.000483	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.98e-06	0.00047	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	4.98e-06	0.00047	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.77e-06	0.00045	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	4.64e-06	0.000438	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	4.51e-06	0.000426	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	4.5e-06	0.000425	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.48e-06	0.000424	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.45e-06	0.000421	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	4.24e-06	0.0004	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.08e-06	0.000385	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	4.06e-06	0.000384	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	3.67e-06	0.000347	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	3.64e-06	0.000344	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CD36—dilated cardiomyopathy	3.57e-06	0.000338	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	3.54e-06	0.000335	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—AGT—dilated cardiomyopathy	3.22e-06	0.000304	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	3.19e-06	0.000301	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	2.63e-06	0.000248	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.58e-06	0.000243	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	2.56e-06	0.000242	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	2.31e-06	0.000218	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	2.28e-06	0.000215	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	2.22e-06	0.000209	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	2e-06	0.000189	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.98e-06	0.000187	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.93e-06	0.000182	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.74e-06	0.000164	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.22e-06	0.000115	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.19e-06	0.000112	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.07e-06	0.000101	CbGpPWpGaD
